ResMed Inc (RMD)
231.40
-4.04
(-1.72%)
USD |
NYSE |
Nov 14, 16:00
228.97
-2.43
(-1.05%)
After-Hours: 20:00
ResMed Research and Development Expense (Quarterly): 79.52M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 79.52M |
| June 30, 2024 | 80.86M |
| March 31, 2024 | 77.07M |
| December 31, 2023 | 73.88M |
| September 30, 2023 | 75.71M |
| June 30, 2023 | 78.14M |
| March 31, 2023 | 76.44M |
| December 31, 2022 | 69.87M |
| September 30, 2022 | 63.19M |
| June 30, 2022 | 64.32M |
| March 31, 2022 | 66.80M |
| December 31, 2021 | 62.51M |
| September 30, 2021 | 59.95M |
| June 30, 2021 | 59.88M |
| March 31, 2021 | 55.94M |
| December 31, 2020 | 54.94M |
| September 30, 2020 | 54.53M |
| June 30, 2020 | 52.52M |
| March 31, 2020 | 51.45M |
| December 31, 2019 | 49.94M |
| September 30, 2019 | 48.03M |
| June 30, 2019 | 51.14M |
| March 31, 2019 | 47.61M |
| December 31, 2018 | 43.11M |
| September 30, 2018 | 38.79M |
| Date | Value |
|---|---|
| June 30, 2018 | 39.66M |
| March 31, 2018 | 37.43M |
| December 31, 2017 | 40.64M |
| September 30, 2017 | 37.42M |
| June 30, 2017 | 36.71M |
| March 31, 2017 | 35.13M |
| December 31, 2016 | 38.19M |
| September 30, 2016 | 34.45M |
| June 30, 2016 | 34.38M |
| March 31, 2016 | 28.11M |
| December 31, 2015 | 28.97M |
| September 30, 2015 | 27.19M |
| June 30, 2015 | 28.52M |
| March 31, 2015 | 27.02M |
| December 31, 2014 | 29.29M |
| September 30, 2014 | 30.02M |
| June 30, 2014 | 31.80M |
| March 31, 2014 | 29.53M |
| December 31, 2013 | 29.54M |
| September 30, 2013 | 27.36M |
| June 30, 2013 | 31.39M |
| March 31, 2013 | 31.19M |
| December 31, 2012 | 30.33M |
| September 30, 2012 | 27.22M |
| June 30, 2012 | 27.91M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
49.94M
Minimum
Dec 2019
80.86M
Maximum
Jun 2024
65.37M
Average
63.75M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 407.00M |
| Globus Medical Inc | 35.38M |
| Abbott Laboratories | 713.00M |
| Becton Dickinson & Co | 302.00M |
| Integra Lifesciences Holdings Corp | 27.44M |